Tags

Type your tag names separated by a space and hit enter

Migraine and the menopause.
J Br Menopause Soc. 2006 Sep; 12(3):104-8.JB

Abstract

The prevalence of migraine peaks during the 40s and an increased association between migraine and menstruation is often noted. Migraine generally improves after the menopause. Although menstrual irregularity, hot flushes and other climacteric symptoms may warrant management with hormone replacement therapy (HRT), there has been some concern that HRT may aggravate migraine and potentially increase the risk of ischaemic stroke. This evidence-based review concludes that migraine is not a contraindication for HRT but continuous-release transdermal estrogen, in the lowest effective dose, is recommended.

Authors+Show Affiliations

City of London Migraine Clinic, London, UK. anne.macgregor@bartsandthelondon.nhs.uk

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16953983

Citation

MacGregor, E Anne. "Migraine and the Menopause." The Journal of the British Menopause Society, vol. 12, no. 3, 2006, pp. 104-8.
MacGregor EA. Migraine and the menopause. J Br Menopause Soc. 2006;12(3):104-8.
MacGregor, E. A. (2006). Migraine and the menopause. The Journal of the British Menopause Society, 12(3), 104-8.
MacGregor EA. Migraine and the Menopause. J Br Menopause Soc. 2006;12(3):104-8. PubMed PMID: 16953983.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Migraine and the menopause. A1 - MacGregor,E Anne, PY - 2006/9/7/pubmed PY - 2006/10/28/medline PY - 2006/9/7/entrez SP - 104 EP - 8 JF - The journal of the British Menopause Society JO - J Br Menopause Soc VL - 12 IS - 3 N2 - The prevalence of migraine peaks during the 40s and an increased association between migraine and menstruation is often noted. Migraine generally improves after the menopause. Although menstrual irregularity, hot flushes and other climacteric symptoms may warrant management with hormone replacement therapy (HRT), there has been some concern that HRT may aggravate migraine and potentially increase the risk of ischaemic stroke. This evidence-based review concludes that migraine is not a contraindication for HRT but continuous-release transdermal estrogen, in the lowest effective dose, is recommended. SN - 1362-1807 UR - https://www.unboundmedicine.com/medline/citation/16953983/Migraine_and_the_menopause_ L2 - http://www.diseaseinfosearch.org/result/4811 DB - PRIME DP - Unbound Medicine ER -